EMERGENT BIOSOLUT (Germany) Buy Hold or Sell Recommendation
| ER4 Stock | EUR 9.49 0.01 0.11% |
Assuming the 90 days trading horizon and complete risk avoidance on your part, our recommendation regarding EMERGENT BIOSOLUT is 'Strong Sell'. Macroaxis provides EMERGENT BIOSOLUT buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ER4 positions.
Check out EMERGENT BIOSOLUT Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as EMERGENT and provide practical buy, sell, or hold advice based on investors' constraints. EMERGENT BIOSOLUT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
EMERGENT |
Execute EMERGENT BIOSOLUT Buy or Sell Advice
The EMERGENT recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on EMERGENT BIOSOLUT. Macroaxis does not own or have any residual interests in EMERGENT BIOSOLUT or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute EMERGENT BIOSOLUT's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
EMERGENT BIOSOLUT Trading Alerts and Improvement Suggestions
| EMERGENT BIOSOLUT is way too risky over 90 days horizon | |
| EMERGENT BIOSOLUT appears to be risky and price may revert if volatility continues | |
| EMERGENT BIOSOLUT has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1.12 B. Net Loss for the year was (223.8 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| EMERGENT BIOSOLUT generates negative cash flow from operations |
EMERGENT BIOSOLUT Returns Distribution Density
The distribution of EMERGENT BIOSOLUT's historical returns is an attempt to chart the uncertainty of EMERGENT BIOSOLUT's future price movements. The chart of the probability distribution of EMERGENT BIOSOLUT daily returns describes the distribution of returns around its average expected value. We use EMERGENT BIOSOLUT price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of EMERGENT BIOSOLUT returns is essential to provide solid investment advice for EMERGENT BIOSOLUT.
| Mean Return | 0.27 | Value At Risk | -10.6 | Potential Upside | 10.55 | Standard Deviation | 7.13 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of EMERGENT BIOSOLUT historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
EMERGENT BIOSOLUT Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to EMERGENT BIOSOLUT or Other sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that EMERGENT BIOSOLUT's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a EMERGENT stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.34 | |
β | Beta against Dow Jones | 4.70 | |
σ | Overall volatility | 6.84 | |
Ir | Information ratio | 0.02 |
EMERGENT BIOSOLUT Volatility Alert
EMERGENT BIOSOLUT is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure EMERGENT BIOSOLUT's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact EMERGENT BIOSOLUT's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.EMERGENT BIOSOLUT Fundamentals Vs Peers
Comparing EMERGENT BIOSOLUT's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze EMERGENT BIOSOLUT's direct or indirect competition across all of the common fundamentals between EMERGENT BIOSOLUT and the related equities. This way, we can detect undervalued stocks with similar characteristics as EMERGENT BIOSOLUT or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of EMERGENT BIOSOLUT's fundamental indicators could also be used in its relative valuation, which is a method of valuing EMERGENT BIOSOLUT by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare EMERGENT BIOSOLUT to competition |
| Fundamentals | EMERGENT BIOSOLUT | Peer Average |
| Current Valuation | 1.34 B | 16.62 B |
| Price To Book | 0.43 X | 9.51 X |
| Price To Sales | 0.42 X | 11.42 X |
| Revenue | 1.12 B | 9.43 B |
| EBITDA | (41.1 M) | 3.9 B |
| Net Income | (223.8 M) | 570.98 M |
| Total Debt | 448.5 M | 5.32 B |
| Cash Flow From Operations | (34.1 M) | 971.22 M |
| Number Of Employees | 18 | 18.84 K |
| Market Capitalization | 1.91 B | 19.03 B |
| Total Asset | 3.17 B | 29.47 B |
| Z Score | 2.4 | 8.72 |
| Net Asset | 3.17 B |
EMERGENT BIOSOLUT Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as EMERGENT . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 9.49 | |||
| Day Typical Price | 9.49 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) | |||
| Relative Strength Index | 68.06 |
About EMERGENT BIOSOLUT Buy or Sell Advice
When is the right time to buy or sell EMERGENT BIOSOLUT? Buying financial instruments such as EMERGENT Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having EMERGENT BIOSOLUT in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Beer and Liquor Thematic Idea Now
Beer and Liquor
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Beer and Liquor theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Beer and Liquor Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in EMERGENT Stock
EMERGENT BIOSOLUT financial ratios help investors to determine whether EMERGENT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EMERGENT with respect to the benefits of owning EMERGENT BIOSOLUT security.